Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: A randomized controlled trial

Transfusion

Volumn 54, Issue 1, 2014, Pages 31-41

  Oremus, Kresimir ^a   Sostaric, Sinisa ^a   Trkulja, Vladimir ^a   Haspl, Miroslav ^a  

^a Special Hospital for Orthopaedic Surgery Akromion   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BLOOD VOLUME; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HUMAN; INTRAOPERATIVE PERIOD; KNEE ARTHROPLASTY; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATION DURATION; OSTEOARTHRITIS; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME; URINE VOLUME;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84891890096     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12224     Document Type: Article

References (44)

1. Bierbaum BE,. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10. (Pubitemid 29068441)
2. Rosencher N, Kerkkamp HEM,. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-469. (Pubitemid 36428328)
3. Wu WC, Smith TS, Henderson WG, Eaton CB, Poses RM, Uttley G, Mor V, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD,. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 2010; 252: 11-17.
4. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM,. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-292.
5. Raut VV, Stone MH, Wroblewski BM,. Reduction of postoperative blood loss after press-fit condylar knee arthroplasty with use of a femoral intramedullary plug. J Bone Joint Surg Am 1993; 75: 1356-1357. (Pubitemid 23331232)
6. Marulanda GA, Ulrich SD, Seyler TM, Delanois RE, Mont MA,. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5: 125-131.
7. Lemaire R,. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008; 90: 1128-1136.
8. Mahdy AM, Webster NR,. Perioperative systemic haemostatic agents. Br J Anaesth 2004; 93: 842-858. (Pubitemid 39585616)
9. Munoz M, Garcia-Erce JA, Villar I, Thomas D,. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang 2009; 96: 1-13.
10. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Fergusson DA,. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2003;(4): CD001888.
11. Spahn DR,. Anemia and patient blood management in hip and knee surgery. Anesthesiology 2010; 113: 482-495.
12. Strumper D, Weber EWG, Gielen-Wiffels S, van Drumpt R, Bulstra S, Slappendel R, Durieux ME, Marcus MAE,. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 2004; 44: 1567-1571. (Pubitemid 39431275)
13. Jones HW, Savage L, White C, Goddard R, Lumley H, Kashif F, Gurusany K,. Postoperative autologous blood salvage drains-are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases. Acta Orthop Belg 2004; 70: 466-473. (Pubitemid 39486952)
14. Mirza SB, Campion J, Dixon JH, Panesar SS,. Efficacy and economics of postoperative blood salvage in patients undergoing elective total hip replacement. Ann R Coll Surg Engl 2007; 89: 777-784. (Pubitemid 350193689)
15. So-Osman C, Nelissen RGHH, Eikenboom HCJ, Brand A,. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery: a randomized pilot study. Transfus Med 2006; 16: 321-328. (Pubitemid 44453753)
16. Innerhofer P, Tilz G, Fuchs D, Luz G, Hobisch-Hagen P, Schobersberger W, Nussbaumer W, Lochs A, Irschick E,. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis. Transfusion 2000; 40: 821-827. (Pubitemid 30620684)
17. Klenerman L, Chakrabarti R, Mackie I, Brozovic M, Stirling Y,. Changes in haemostatic system after application of a tourniquet. Lancet 1977; 309: 970-972. (Pubitemid 8084106)
18. Risberg B,. The response of the fibrinolytic system in trauma. Acta Chir Scand Suppl 1985; 522: 245-271. (Pubitemid 15066822)
19. Mannucci PM,. Hemostatic drugs. N Engl J Med 1998; 339: 245-253. (Pubitemid 28350168)
20. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-1032. (Pubitemid 29313210)
21. Ho KM, Ismail H,. Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003; 31: 529-537. (Pubitemid 37265248)
22. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S,. Do antifibrinolytics reduce allogenic blood transfusion in orthopedic surgery? Anesthesiology 2006; 105: 1034-1046. (Pubitemid 44655516)
23. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W,. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123: 687-696.
24. Cid J, Lozano M,. Tranexamic acid reduces allogenic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005; 45: 1302-1307. (Pubitemid 41647794)
25. Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F,. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008; 48: 519-525. (Pubitemid 351294580)
26. McGonagle L, Hakkalamani S, Carroll FA,. Tranexamic acid and re-infusion drains in total knee arthroplasty. Eur J Orthop Surg Traumatol 2010; 20: 553-555.
27. Hourlier H, Fennema P,. Chemoprophylaxis without intra-articular wound drainage can replace autotransfusion in primary TKA. Orthopedics 2011; 34: 154.
28. Yamasaki S, Masuhara K, Fuji T,. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005; 87: 766-770. (Pubitemid 40489352)
29. Sukeik M, Alshryda S, Haddad FS, Mason JM,. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011; 93: 39-46.
30. Sehat KR, Evans RL, Newman JH,. Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 2004; 86: 561-565. (Pubitemid 38660062)
31. Good L, Peterson E, Lisander B,. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90: 596-599. (Pubitemid 36592332)
32. Martin K, Wiesner G, Breuer T, Lange R, Tassani P,. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107: 1783-1790.
33. Nardi K, Pelone G, Bartolo M, Di Ruzza MR, Storto M, Notte A, Grillea G, Colonnese C, Lembo G, Vecchione C,. Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T. Ann Clin Biochem 2011; 48: 575-578.
34. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417. (Pubitemid 29084771)
35. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J,; for the FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
36. Goldman M, Remy-Prince S, Trepanier A, Decary F,. Autologous donation error rates in Canada. Transfusion 1997; 37: 523-527. (Pubitemid 27203944)
37. Vamvakas EC,. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogenic and autologous blood transfusion. Vox Sang 2002; 83: 339-346. (Pubitemid 35434356)
38. Bern MM, Bierbaum BE, Katz JN, Losina E,. Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty. Transfus Med 2006; 16: 313-319. (Pubitemid 44453752)
39. Zohar E, Fredman B, Ellis M, Luban I, Stern A, Jedeikin R,. A comparative study of the postoperative allogenic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement. Anesth Analg 1999; 89: 1382-1387.
40. Rosencher N, Poisson D, Albi A, Aperce M, Barré J, Samama CM,. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 2005; 52: 160-165. (Pubitemid 40467973)
41. Unger EF, Thompson AM, Blank MJ, Temple R,. Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med 2010; 362: 189-192.
42. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M,. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
43. Blanchette CM, Wang PF, Joshi AV, Kruse P, Asmussen M, Saunders W,. Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals. Adv Ther 2006; 23: 54-67.
44. Blanchette CM, Joshi AV, Szpalski M, Gunzburg R, Du Bois M, Donceel P, Saunders WB,. Burden of blood transfusion in knee and hip surgery in the US and Belgium. J Med Econ 2009; 12: 171-179.